公开(公告)号：US20050221613A1

公开(公告)日：2005-10-06

申请号：US11142331

申请日：2005-06-02

申请人： Ryoh Ozaki ,  Hitomi Ohta ,  Hiroyuki Fukumura ,  Yoshiroh Takaba ,  Yuji Komatsu ,  Tohru Nunoi

发明人： Ryoh Ozaki ,  Hitomi Ohta ,  Hiroyuki Fukumura ,  Yoshiroh Takaba ,  Yuji Komatsu ,  Tohru Nunoi

IPC分类号： H01L31/04 ,  H01L21/44 ,  H01L31/0224 ,  H01L31/068

CPC分类号： H01L31/022425 ,  H01L31/068 ,  Y02E10/547

摘要： A method for forming an electrode according to the present invention includes a step of discharging a paste containing an electrode material from a discharge port of a nozzle, and drawing a fine-line pattern on a surface of a semiconductor substrate, and a step of drying and baking the drawn fine-line pattern, and forming a fine-line electrode. Herein, in the drawing step, the nozzle is arranged so that a central axis of the nozzle is inclined at a predetermined inclination angle with respect to the surface of the semiconductor substrate, and so that the discharge port is proximate to the surface of the semiconductor substrate at a predetermined distance, the nozzle and the semiconductor substrate are moved relatively to each other in a drawing direction of the fine-line pattern, and relative movement speeds of the nozzle and the semiconductor substrate are adjusted, thereby drawing the fine-line pattern so that a line width of the fine-line pattern is smaller than an inner diameter of the discharge port of the nozzle.

摘要翻译： 根据本发明的电极形成方法包括从喷嘴的排出口排出含有电极材料的糊剂，并在半导体衬底的表面上绘制细线图案的步骤，以及干燥步骤 并烘烤所绘制的细线图案，并形成细线电极。 这里，在拉拔工序中，喷嘴被配置为使得喷嘴的中心轴相对于半导体基板的表面以预定的倾斜角倾斜，并且使得排出口靠近半导体的表面 衬底在预定距离处，喷嘴和半导体衬底沿着细线图案的拉伸方向彼此相对移动，并且调节喷嘴和半导体衬底的相对移动速度，从而绘制细线图案 使得细线图案的线宽小于喷嘴的排出口的内径。

公开(公告)号：US20120035187A1

公开(公告)日：2012-02-09

申请号：US13146840

申请日：2010-01-25

申请人： Hitomi Ohta ,  Kenji Akita ,  Tsunetaka Ohta ,  Toshio Kawata ,  Shigeharu Fukuda

发明人： Hitomi Ohta ,  Kenji Akita ,  Tsunetaka Ohta ,  Toshio Kawata ,  Shigeharu Fukuda

IPC分类号： A61K31/496 ,  C07D417/14 ,  C07D263/57 ,  C07D213/38 ,  C07D417/06 ,  C07D413/06 ,  C07D403/06 ,  C07D403/14 ,  A61K31/4709 ,  A61K31/427 ,  A61K31/428 ,  A61K31/423 ,  A61K31/44 ,  A61K31/404 ,  A61P25/00 ,  A61P25/28 ,  A61P25/16 ,  A61P3/10 ,  A61P27/02 ,  A61P35/04 ,  A61P17/04 ,  A61P39/06 ,  A61P35/00 ,  C07D401/14

CPC分类号： C07D277/22 ,  C07D209/14 ,  C07D213/74 ,  C07D215/06 ,  C07D215/12 ,  C07D231/22 ,  C07D235/20 ,  C07D261/12 ,  C07D263/56 ,  C07D277/28 ,  C07D277/64 ,  C07D277/84 ,  C07D311/74 ,  C07D333/32 ,  C07D333/64 ,  C07D405/06 ,  C07D413/06 ,  C07D417/06

摘要： The present invention has an object to provide a novel agent for anti-neurodegenerative diseases and solves the object by providing an agent for anti-neurodegenerative diseases containing, as an effective ingredient, the compound(s) represented by the following General formula 1: wherein in General formula 1, R1 through R3 independently represent a hydrogen atom or an appropriate substituent; Z1 represents a heterocyclic ring and Z2 represents the same or different heterocyclic or aromatic ring as in Z1, wherein the heterocyclic and aromatic rings optionally have a substituent; represents an integer of 0, 1 or 2; p represents an integer of 0 or 1, with the proviso that p is 1 when o is 0 or 2, and p is 0 when o is 1; R1 and R2 do not exist when o is 0, while, when p is 0, R3 does not exist and the binding between the carbon atom to which R2 binds and Z2 is a single bond; X1− represents an appropriate counter anion and q represents an integer of 1 or 2.

摘要翻译： 本发明的目的是提供抗神经退行性疾病的新型药剂，通过提供含有下述通式1表示的化合物作为有效成分的抗神经变性疾病试剂来解决本发明的目的：其中 在通式1中，R 1至R 3独立地表示氢原子或适当的取代基; Z1表示杂环，Z2表示与Z1中相同或不同的杂环或芳环，其中杂环和芳环任选具有取代基; 表示0,1或2的整数; p表示0或1的整数，条件是当o为0或2时p为1，当o为1时p为0; 当o为0时，R1和R2不存在，而当p为0时，R3不存在，R2结合的碳原子与Z2为单键的结合; X 1表示适当的抗衡阴离子，q表示1或2的整数。

公开(公告)号：US20090023684A1

公开(公告)日：2009-01-22

申请号：US11912279

申请日：2006-04-13

申请人： Hitomi Ohta ,  Toshiharu Hanaya ,  Shigeharu Fukuda ,  Yoshikatsu Miwa ,  Toshio Miyake

发明人： Hitomi Ohta ,  Toshiharu Hanaya ,  Shigeharu Fukuda ,  Yoshikatsu Miwa ,  Toshio Miyake

IPC分类号： A61K31/715

CPC分类号： A61K31/716 ,  A61K31/702 ,  A61K31/7048 ,  A61M1/287 ,  A61K2300/00

摘要： The present invention has an object to provide a fluid for peritoneal dialysis with satisfactory body fluid removability, high biocompatibility, and improved storage stability, and the object is attained by a fluid for peritoneal dialysis containing one or more saccharides selected from cyclonigerosylnigerose, cyclomaltosylmaltose, and L-ascorbic acid 2-glucoside.

摘要翻译： 本发明的目的是提供一种用于腹膜透析的流体，其具有令人满意的体液清除性，高生物相容性和改善的储存稳定性，并且目的是通过含有一种或多种选自旋风黑素糖， L-抗坏血酸2-葡萄糖苷。